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Abstract
Background. Recent history of measles epidemiology in Italy is characterized by the 
recurrence of spatially localized epidemics.  
Aim. In this study we investigate the three major outbreaks occurred in Italy over the 
period 2010-2011 and estimate the measles transmission potential. The epidemics 
mainly involved individuals aged 10-28 years and the transmission potential, measured 
as effective reproduction number – i.e. the number of new infections generated by a 
primary infector – was estimated to be 1.9-5.9.
Results. Despite such high values, we found that, in all investigated outbreaks, the 
reproduction number has remained above the epidemic threshold for no more than 
twelve weeks, suggesting that measles may hardly have the potential to give rise to new 
nationwide epidemics.
Conclusion. In conclusion, the performed analysis highlights the need of planning 
additional vaccination programs targeting those age classes currently showing a higher 
susceptibility to infection, in order not to compromise the elimination goal by 2015.
INTRODUCTION
In September 2010, Member States in the WHO Eu-
ropean Region set themselves 2015 as the new target 
date for eliminating measles and rubella [1]. However, 
even if Europe is on the way to measles elimination, 
the virus is currently still circulating in most Europe-
an countries [2]. For instance in 2011, more than 15 
000 cases were recorded in France, with a monthly 
maximum of 3726 cases in March, 5181 cases were re-
ported in Italy, 4015 in Romania and more than 1000 
cases were reported in Spain, Germany and the UK [2]. 
Moreover, from July 2013 to June 2014, 7116 cases 
were reported from 30 EU/EEA countries conducting 
measles surveillance. Germany, Italy and the Nether-
lands accounted for 77.3% of the cases in this period 
and 6 European countries reporting outbreaks (Spain, 
The Netherlands, Belgium, Latvia, Czech Republic and 
Sweden) [3]. This generates serious concerns about the 
possibility of reaching the target within 2015 [4].
A single-antigen measles vaccine was introduced in 
Italy in 1976: measles-mumps-rubella (MMR) vaccine 
has been recommended since the early 1990s. Initially, 
a single dose of a measles-containing vaccine was rec-
ommended for children aged 15 months. Later, in 1999, 
the age of administration of the first dose (of MMR 
vaccine) was lowered to 12 months. From 1999 the 
Ministry of Health recommended the Regional Health 
Authorities to actively offer the MMR vaccine free of 
charge and to administer a second dose of MMR vac-
cine in regions that had reached a coverage level of 80% 
or higher for the first dose [5]. Since 2003, a National 
Plan for the Elimination of measles and congenital Ru-
bella was implemented and recommended two doses 
of MMR vaccine in all regions: the first dose at 12-15 
months and the second at the age of 5-6 years or 11-12 
years. Moreover the Plan requested to all Regions in 
Italy (21) in an extra-ordinary effort to perform a catch-
up vaccination program using all occasion of contact 
of children (who had not yet received the two recom-
mended MMR vaccine doses) with vaccination servic-
es, including a campaign aimed at inviting all school age 
children in primary and lower secondary schools [5]. 
At the time of measles vaccine introduction, the cov-
erage for the first dose was only 6%, and then the level 
quickly increased until remaining around 90% in the last 
5 years [6], while for the second dose it increased from 
about 51% in 1999 to about 75% from 2006 to nowa-
days [5]. Such vaccination effort led to a substantial de-
crease of measles incidence and to a dramatic change 
in its epidemiology. In fact, Italy is no more subject to 
large nationwide epidemics and, in recent years, mea-
sles dynamics were characterized by the occurrence of 
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several spatially localized outbreaks ranging from a few 
cases up to more than a thousand cases [7]. 
Factors concurring to this increase include subopti-
mal routine vaccination coverage (< 95%) that cause 
large numbers of susceptible adolescents and young 
adults born in the 1980s and 1990s, when measles vac-
cine uptake was very low and the second dose had not 
yet been introduced. 
Adolescents and young adults have been frequently af-
fected in outbreaks in recent years, but there continue 
to be high levels of susceptibility in these age groups [6]. 
Incidence varied greatly among geographical regions, 
and factors such as local epidemiology and accumula-
tion of susceptible groups, but also difference in under-
reporting, may account for these differences [7]. 
The present study aims to better understand the dy-
namics of recent local outbreaks (e.g., in terms of final 
impact, timing and age distribution of cases) and to 
estimate the current measles transmission potential in 
Italy, in order to give insights for the design of adequate 
immunization plans in such a way to speed up the elimi-
nation goal by 2015.
METHODS
Measles surveillance system in Italy
The Italian measles surveillance system has been pre-
viously described [7, 8]. Measles has been statutorily 
notifiable in Italy since 1934. An enhanced surveillance 
system was introduced in 2007 to improve timeliness, 
completeness of case reporting, and case investiga-
tion, including laboratory confirmation of diagnosis [8]. 
Briefly, according to this system, physicians are required 
to report all suspected measles cases to the local health 
authorities within 12 hours. For each suspected case, 
the local health authorities are required to carry out 
an epidemiological investigation, including obtaining 
specimens for laboratory confirmation and genotyping 
and to complete a standard measles notification form, 
which is then to be sent to regional health authorities. 
The regional authorities forward the forms immediately 
to the Ministry of Health and to the Infectious Diseases 
Epidemiology Unit of the National Center for Epide-
miology Surveillance and Health Promotion of the Na-
tional Institute of Health. 
Cases are then classified as probable, possible and 
confirmed at national level using the European Union 
case definition [9]. Cases classified as “non cases” on 
the basis of the laboratory investigation were excluded 
from the analysis.
To investigate measles transmission potential in Italy, 
we analyze cases on the three largest epidemics report-
ed to the national surveillance system over the period 
2010-2011 from 3 Region and Autonomous Provinces 
(Lazio, PA of Trento and PA of Bolzano) [7, 8]. The 
Lazio experienced two outbreaks in the considered pe-
riod [10]; however in this article we consider only the 
epidemic occurred in 2010. Data were extracted from 
the surveillance system database in April 2013.
Mathematical model
A population will rarely be totally susceptible to an 
infection in the real world. To such aim, we make use 
of the concept of effective reproduction number (R), 
which is defined as the average number of secondary 
cases per infectious case in a population made up of 
both susceptible and non-susceptible hosts and repre-
sents a measure for the transmission potential of an in-
fectious disease.
In fact, the basic reproduction number is the average 
number of secondary cases generated by a typical in-
dex case in a fully susceptible population. The effective 
reproduction number, the one considered in our work, 
accounts for reduced transmissibility due to the pres-
ence of a large fraction of protected individuals in the 
population (typical of childhood diseases when a large 
fraction of adults is immune). Reproduction numbers 
are key parameters because they are related to the final 
size of the epidemic. Basically, if the reproduction num-
ber is lower than 1 the epidemic goes extinct, otherwise 
an epidemic outbreak can be observed and the final size 
will be proportional to the reproduction number itself. 
The estimation procedure we use for computing the 
maximum value of R is widely adopted in the literature 
[11-16] and can be briefly described as follows:
a) Given the intrinsic uncertainty in all notification 
data, we use a Poisson distribution having mean 
equal to the weekly number of reported cases to 
generate 10 000 simulated time series of measles 
weekly cases.
b) For each time series, we estimate the exponential 
growth rate of the epidemic r by fitting a linear 
model to the logarithm of the number of new cases 
in the three-weeks time window showing the larg-
est growth rate [16].
c) We model measles transmission flow as follows: 
susceptible individuals can acquire the disease 
(and enter in the latent stage) through contact with 
infectious individuals during both prodromal and 
exanthema phase; before recovering an infected 
individual undergoes latent, prodromal and exan-
thema phases, lasting on average 10, 4 and 4 days, 
respectively [17]. Given this model, the following 
relation between the effective reproduction num-
ber R and the exponential growth rate r holds [18]:
 
where 1/ω, 1/γ and 1/δ represent the average duration 
of latent, prodromal and exanthema phases, respective-
ly, and k represents the fraction of cases generated by a 
primary infector during the exanthema phase, and con-
sequently (1-k) refers to the fraction of cases generated 
during the prodromal phase – we explore k in the range 
10%-50% as no precise information is available. We de-
cide to use this range (10%-50% during the exanthema 
phase) to explore a very large range of possibilities but 
we also assume that transmission is lower during the ex-
anthema phase (in this phase, individuals are assumed 
to stay at home and thus can infect less individuals with 
respect to the prodromal phase). This is why we assume 
50% as upper limit for the  proportion of cases during 
the exanthema phase.
Starting from the original weekly number Xt of cases 
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Figure 1
Graphical representation of the performed epidemiological analysis. In order to guarantee the stability of the results, the procedure 
is repeated 10 000 times.
Figure 2
Spatial location and weekly number of cases reported to the national surveillance system. Only the three major epidemics occurred 
in Italy over the period 2010-2011 are shown. 
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observed at time t, we simulate different time series of 
data Yt by sampling, at each time t, from a Poisson dis-
tribution of mean Xt, to account for stochastic effects. 
The time window depends on the duration of the ana-
lyzed outbreak and may vary from region to region.
In Figure 1 a graphical representation of the above 
described procedure is shown. In addition, in order to 
estimate the effective reproduction number over the 
entire course of the epidemic, the same method can be 
applied to each three-weeks time window of the epi-
demic [14, 19]. Finally, the uncertainty of our estimates 
of the transmission potential is obtained by combining 
the uncertainty in both the reporting system and k. Spe-
cifically, R ranges we present refer to the upper 95% 
CI of r combined with the larger value of k and to the 
lower 95% CI of r combined with the lower value of k. 
The algorithm was implemented in the statistical pack-
age R [20].
RESULTS
Over the period 2010-2011 Italy experienced three 
major measles epidemics. The first one spread from 
mid April 2010 until October 2010 in Lazio (Central 
Italy): the total number of cases reported to the surveil-
lance system is 910, the average age is 20.8 years and 
50% of cases are aged 14-28 years. The Lazio region 
experienced an outbreak also in 2011 [10], however, in 
this article we consider the epidemic occurred in 2010. 
The second epidemic spread from mid September 2010 
until the end of December 2010 in the Autonomous 
Province of Trento (PA Trento, Northern Italy): the to-
tal number of reported cases is 400, the average age is 
17.4 years and 50% of cases are aged 13-21 years. The 
third one spread from mid March 2011 until mid Au-
gust 2011 in the Autonomous Province of Bolzano (PA 
Figure 3
Estimated effective reproduction number. Panel A) Estimated maximum value of the effective reproduction number as a function of 
the fraction of cases generated during the exanthema phase, for the epidemic in Lazio (left), PA Trento (center) and PA Bolzano (right). 
Solid lines represent averages, shaded areas represent 95% CI. Panel B) Estimated range for the maximum value of effective reproduc-
tion number plotted against the average age of the reported cases during the epidemic in Lazio (light grey), PA Trento (grey) and PA 
Bolzano (dark grey).
Figure 4
Effective reproduction number over time. Panel A) Estimated 
range of the effective reproduction number over time during 
the epidemic in Lazio. Panel B) Estimated range of the effec-
tive reproduction number over time during the epidemic in PA 
Trento. Panel C) Estimated range of the effective reproduction 
number over time during the epidemic in PA Bolzano.
The horizontal line represents the epidemic threshold R = 1; R 
at week t is computed by considering the three-weeks moving 
window from t - 1 to t + 1.
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Bolzano, Northern Italy): the total number of reported 
cases is 1110, the average age is 13.8 years and 50% of 
cases are aged 10-17 years. Epidemic profiles and the 
spatial location of the outbreaks are shown in Figure 2.
The exponential growth rate is estimated to be 0.56 
(95% CI: 0.37-0.90), 0.75 (95% CI: 0.45-1.02) and 
0.91 (95% CI: 0.65-1.22) per week for the epidemic 
in Lazio, PA Trento and PA Bolzano, respectively. This 
leads to an effective reproduction number in the range 
1.9-4.2, 2.1-4.8 and 2.7-5.9 for the epidemic in Lazio, 
PA Trento and PA Bolzano respectively (see Figure 3A). 
Moreover, we find that the estimated value of R increas-
es as the average age of reported cases decreases (see 
Figure 3B).
Finally, as shown in Figure 4, in the three epidemics 
the effective reproduction number remains above the 
epidemic threshold (R = 1) for less than twelve weeks 
since the beginning of the outbreak. 
DISCUSSION
Two main conclusions can be drawn from our epide-
miological analysis. First, at a local scale the current 
measles transmission potential can still be high, giving 
rise to spatially localized outbreaks. Specifically, we es-
timate the maximum value of the effective reproduction 
number to be in the range 1.9-5.9, during the three larg-
est epidemics occurred over the period 2010-2011. This 
range is remarkably above the unit; however, it is lower 
than that observed during the 70s in Italy [21], when 
the country experienced nationwide epidemics. 
Moreover, data show that in the three major epidem-
ics R is estimated to be above the epidemic threshold 
for less than twelve weeks since the beginning of the 
outbreak. This common pattern suggests that, given the 
current immunization level in the Italian population, 
measles has no more the potential to give rise to nation-
wide epidemics, however, it should be considered that 
simultaneous local outbreaks can derive by a unique 
“index case”. 
Second, the analysed epidemics mainly involved ado-
lescents and young adults. This suggests that the ages 
that are currently more susceptible to measles infec-
tions lie in the range 10-28 years, mainly as a conse-
quence of the ongoing children immunization program 
which is leading to a remarkable drop in the number of 
yearly cases and to an increase in the age at infection. 
Nonetheless, our analysis reveals that infections in 
lower ages are associated to larger values of the effec-
tive reproduction number, suggesting that measles has 
the capability to better spread in children than in the 
other age classes. It should be noted that the lower av-
erage age of cases reported in the PA Bolzano is due to 
the lower vaccine coverage for measles among children 
at 24 months of age (72.4%) with respect to the average 
national coverage (90.1%). In fact, vaccination coverag-
es in Italy are quite variable across regions: for instance, 
in 2011 measles vaccine coverage at 24 months of age 
ranged from 72.4% of the PA of Bolzano (Northern Ita-
ly), to 82.5% in Calabria (Southern Italy), to more than 
92% in Puglia (Southern Italy), Piedmont (Northern 
Italy), Marche and Tuscany (Central Italy) [5].
Our study as others study relying on surveillance data 
has a potential limitation due to a certain degree of un-
derreporting. Since the introduction of the enhanced 
surveillance system in Italy in 2007 [8], reporting and 
completeness of cases is improved, however we cannot 
exclude the possibility of a certain degree of under-
reporting. In late 90s and early 2000s, on the basis of 
data reported by a sentinel surveillance system relying 
on paediatricians (SPES), measles incidence was esti-
mated to be 10 times greater than incidence estimated 
through the statutory notifications [22, 23]. Thus, for 
the Lazio region, data from the National enhanced sur-
veillance system have shown a total of 910 cases in 2010 
compared to the 1054 cases (incidence rate of 18.4 x 
100 000) reported by Regional Public Health Authori-
ties [10], that is well below the 10 times degree of un-
derreporting previously recorded. 
In 2011, the Italian Ministry of Health published a 
new national elimination plan approved by the State-
Regions collegial body (Conferenza Stato Regioni), 
which means that all 21 regions have committed to 
the objectives and strategies included in the plan [24]. 
The plan, which includes all components of the WHO 
elimination strategy, comprises also specific measures 
to be considered in case of an outbreak (i.e. isolation 
of cases and vaccination of close contacts). However, 
since several local outbreaks are still ongoing in Italy 
[3], in order not to jeopardize the elimination goal by 
2015, there is an urgent need of vaccination strategies 
aimed at covering those age classes (mainly adolescents 
and young adults) that are currently more susceptible 
to the disease.
Surely additional immunisation efforts (e.g new 
catch-up campaign) should be considered for suscepti-
ble groups above described: this call for new modelling 
studies for evaluating the effectiveness of targeted vac-
cination strategies. An intriguing hypothesis would be 
to reinforce the two-dose vaccination program currently 
in place by offering the vaccine, only for one year, in 
lower and upper secondary schools in order to immu-
nize the 11-16 age brackets. As a matter of fact, optimi-
sation of vaccination programme design can be greatly 
facilitated through insights gained from the mathemati-
cal modelling of measles transmission dynamics [25].
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